Equillium Inc (EQ)
1.54
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.55
+0.01
(+0.65%)
Pre-Market: 20:00
Equillium Cash from Investing (Quarterly): -2.831M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.831M |
| December 31, 2023 | -5.566M |
| September 30, 2023 | 10.98M |
| June 30, 2023 | 15.00M |
| March 31, 2023 | -25.18M |
| December 31, 2022 | 6.978M |
| September 30, 2022 | 15.00M |
| June 30, 2022 | 8.691M |
| March 31, 2022 | -11.98M |
| December 31, 2021 | -16.89M |
| September 30, 2021 | 10.47M |
| June 30, 2021 | 28.97M |
| March 31, 2021 | 4.86M |
| Date | Value |
|---|---|
| December 31, 2020 | -17.04M |
| September 30, 2020 | -23.02M |
| June 30, 2020 | 8.455M |
| March 31, 2020 | 13.00M |
| December 31, 2019 | -5.33M |
| September 30, 2019 | -0.225M |
| June 30, 2019 | 6.04M |
| March 31, 2019 | -2.651M |
| December 31, 2018 | -37.41M |
| September 30, 2018 | -0.003M |
| June 30, 2018 | -0.017M |
| March 31, 2018 | -0.005M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.18M
Minimum
Mar 2023
28.97M
Maximum
Jun 2021
1.020M
Average
5.45M
Median
Cash from Investing (Quarterly) Benchmarks
| Janux Therapeutics Inc | -113.74M |
| Mersana Therapeutics Inc | -72.55M |
| Vera Therapeutics Inc | -219.29M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.80M |
| Free Cash Flow | -22.66M |
| Free Cash Flow Per Share (Quarterly) | -0.2502 |
| Free Cash Flow to Equity (Quarterly) | -8.819M |
| Free Cash Flow to Firm (Quarterly) | -8.819M |
| Free Cash Flow Yield | -42.11% |